Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-056)
- Status
- TERMINATED
- Phase
- PHASE1
Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
TrasGEX™: Phase 1 Study in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
The Effects of Ginseng on Cancer-Related Fatigue
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
- Status
- TERMINATED
- Phase
- NA
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor
- Status
- COMPLETED
- Phase
- N/A
A Study of LY2523355 in Patients With Solid Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
BIBF 1120 and RAD001 in Solid Tumors - Phase I
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility Clinical Study of Targeted and Genome-Wide Sequencing
- Status
- COMPLETED
- Phase
- N/A
A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)
- Status
- COMPLETED
- Phase
- PHASE2